| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.17 | 0.004 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.17 | 0.004 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.16 | 0.004 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.13 | 0.005 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.005 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.006 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.007 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.007 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.007 |